Lineage Cell Therapeutics, Inc. · AMEX:LCTX

Broadwood Partners, L.P. bought 1,000,000 Lineage Cell Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Broadwood Partners, L.P. (Director, 10% owner) bought 1,000,000 Lineage Cell Therapeutics, Inc. shares at US$0.77 for US$771K, leaving 50,560,992 shares. Filed Nov 19, 2026 (Form 4).

Bought
1,000,000 shares
Price
US$0.77
Value
US$771K
Holding after
50,560,992 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common SharesBuy1,000,000US$0.7750,560,992Direct
Nov 17, 2026Common SharesBuy050,560,992Indirect

Source

Download original · View original at SEC

Related